CN Patent

CN106588753B — 一种制备匹马色林的方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2021-07-09 · 5y expired

What this patent protects

本发明涉及一种匹马色林的制备方法。该方法以4‑异丁氧基苯甲醛为起始原料，反应条件温和，避免了气体反应物料，产品收率高，工艺操作简单，无特殊设备要求，尤其适合工业化生产。

USPTO Abstract

本发明涉及一种匹马色林的制备方法。该方法以4‑异丁氧基苯甲醛为起始原料，反应条件温和，避免了气体反应物料，产品收率高，工艺操作简单，无特殊设备要求，尤其适合工业化生产。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN106588753B
Jurisdiction: CN
Classification: —
Expires: 2021-07-09
Drug substance claim: No
Drug product claim: No
Assignee: Chongqing Pharmaceutical Research Institute Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.